# BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)

> clinical trial · VERIFIED · 2026-08-26

Status: COMPLETED · Sponsor: ETOP IBCSG Partners Foundation · Condition: Lung Cancer

- Company: ETOP IBCSG Partners Foundation
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT01562028

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.